⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13678300 | 0.76 | — | — | |
| SCHEMBL265303 | 0.76 | — | — | |
| SCHEMBL12309935 | 0.76 | — | — | |
| SCHEMBL18602348 | 0.74 | — | — | |
| SCHEMBL10027830 | 0.72 | CACNA2D1 (0.44) | — | |
| SCHEMBL12251291 | 0.72 | — | — | |
| SCHEMBL10595937 | 0.71 | — | — | |
| SCHEMBL264513 | 0.71 | — | — | |
| SCHEMBL2762351 | 0.71 | — | — | |
| SCHEMBL11115125 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9200113-B2 | Multi-amine functional oligomers and method for producing the same by the reduction of corresponding oximes | COVESTRO DEUTSCHLAND AG (DE) | 2015-12-01 | — | — | US | disclosed |
| EP-1040094-B9 | SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARM INC (US) | 2015-09-09 | — | — | EP | disclosed |
| US-20130066112-A1 | MULTI-AMINE FUNCTIONAL OLIGOMERS AND METHOD FOR PRODUCING THE SAME BY THE REDUCTION OF CORRESPONDING OXIMES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-03-14 | — | — | US | disclosed |
| EP-2545101-A2 | MULTI-AMINE FUNCTIONAL OLIGOMERS AND METHOD FOR PRODUCING THE SAME BY THE REDUCTION OF CORRESPONDING OXIMES | Bayer Intellectual Property GmbH (DE) | 2013-01-16 | — | — | EP | disclosed |
| WO-2011110535-A2 | MULTI-AMINE FUNCTIONAL OLIGOMERS AND METHOD FOR PRODUCING THE SAME BY THE REDUCTION OF CORRESPONDING OXIMES | BAYER MATERIALSCIENCE AG (DE) | 2011-09-15 | — | — | WO | disclosed |
| EP-1040094-B1 | SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARM INC (US) | 2009-03-18 | — | — | EP | disclosed |
| US-7038059-B2 | Process for preparation of 4-n-substituted amino-2-aza-1-oxabicyclo[3.3.0] oct-2-ene-6-carboxylic acid esters and process for preparation of their intermediates | KURARAY CO., LTD. (JP) | 2006-05-02 | — | — | US | disclosed |
| EP-1040094-A4 | SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARM INC (US) | 2004-12-08 | — | — | EP | disclosed |
| US-20040121482-A1 | Process for preparation of 4-n-substituted amino-2-aza-1-oxabicyclo[3.3.0] oct-2-ene-6-carboxylic acid esters and process for preparation of their intermediates | KURARAY CO., LTD. (JP) | 2004-06-24 | — | — | US | disclosed |
| EP-1334969-A1 | PROCESS FOR PREPARATION OF 4-N-SUBSTITUTED AMINO-2-AZA-1-OXABICYCLO 3.3.0]OCT-2-ENE-6-CARBOXYLIC ACID ESTERS AND PROCESS FOR PREPARATION OF THEIR INTERMEDIATES | KURARAY CO., LTD. (JP) | 2003-08-13 | — | — | EP | disclosed |
| US-6562861-B1 | (1R,3R,4R,1'S)-(-)-(1'-acetylamino-2 '-ethyl)butyl-4-(aminoimino)methylaminocyclopentan-1-carboxylic acid was prepd. and tested in vitro as neuraminidase inhibitor (IC50 less-than 1.mu.M). Bactericides or viricides | BIOCRYST PHARMACEUTICALS, INC. | 2003-05-13 | — | — | US | disclosed |
| EP-1040094-A1 | SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARMACEUTICALS INC. (US) | 2000-10-04 | — | — | EP | disclosed |
| WO-1999033781-A1 | SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS | BIOCRYST PHARMACEUTICALS, INC. (US) | 1999-07-08 | — | — | WO | disclosed |